News Novartis aims to broaden use of breast cancer drug Study shows Kisqali extends survival in younger women with aggressive disease
News Eisai: UK gives pharma a poor deal, may invest elsewhere Japanese pharma getting frustrated with NICE
News US regulator approves new use for Pfizer's Sutent FDA granted new kidney cancer indication despite advisers' split decision
News Angelini Pharma's R&D chief heads for the exit Dr Rafal Kaminski's near five-year tenure as chief scientific officer of Italy's Angelini Pharma will come to an end in the next couple of weeks.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.